Cancer Trial King is Worth a Look as It Keeps on Growing in a Growing Medical World
Hello Share Swappers. Medical companies have a favourable spot in my humble musings on possible share success. Today’s choice for your further perusal is Ergomed (ERGO). This is a niche company, another reason for me to favour it.
- By Malcolm Stacey
- 2022-08-16 08:15:53